Cite
HARVARD Citation
Pender, A. et al. (n.d.). The efficacy of crizotinib in patients with ALK-positive nonsmall cell lung cancer. Therapeutic advances in respiratory disease. pp. 97-104. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Pender, A. et al. (n.d.). The efficacy of crizotinib in patients with ALK-positive nonsmall cell lung cancer. Therapeutic advances in respiratory disease. pp. 97-104. [Online].